You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Merck
AstraZeneca
Colorcon

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

TICAR Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Ticar, and what generic alternatives are available?

Ticar is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.

Summary for TICAR
Drug patent expirations by year for TICAR
Synonyms for TICAR
(2S,5R,6R)-6-[[(2R)-3-hydroxy-3-oxo-2-(3-thienyl)propanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-CARBOXY-3-THIENYLACETYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID DISODIUM SALT
29457-07-6
29457-07-6,34787-01-4(freebase)
3-Thiophenemalonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicylo(3.2.0)hept-6-yl)-, disodium salt
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, disodium salt, (2S-(2alpha,5alpha,6beta(S*)))-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-carboxy-3-thienylacetyl]amino]-3,3-dimethyl-7-oxo-, disodiumsalt, (2S,5R,6R)-
4697-14-7
74682-62-5
A-8642
A822398
A827122
AB 2288
AC-4338
Aerugipen
Aerugipen hydrate
AK175824
AKOS025402077
AKOS027250787
AKOS027276160
API0004413
BCP11971
BCP13459
BIT0186
BRL 2288
BRL-2288
C-22212
C14021
CAS-4697-14-7
CC-35060
CHEBI:35017
CHEMBL1200855
CS-4785
D02241
DB-070767
Disodium (2S-(2alpha,5alpha,6beta(S*)))-6-(carboxylato-3-thienylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
disodium (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-3-oxidanidyl-3-oxidanylidene-2-thiophen-3-yl-propanoyl]amino]-7-oxidanylidene-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-[[(2R)-2-carboxylato-1-oxo-2-(3-thiophenyl)ethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Disodium (2S,5R,6R)-6-[2-carboxylato(thiophen-3-yl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium (2S,5R,6R)-6-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
disodium 6beta-{[(2R)-2-carboxylato-2-thiophen-3-ylacetyl]amino}-2,2-dimethylpenam-3alpha-carboxylate
Disodium Ticarcillin
disodium;(2S,5R,6R)-6-[(2-carboxylato-2-thiophen-3-ylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
DSSTox_CID_25561
DSSTox_GSID_45561
DSSTox_RID_80958
DTXSID8045561
EINECS 249-642-5
G8TVV6DSYG
HMS1571E16
HMS2098E16
HY-B1175
LS-153103
Monapen
N-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-3-thiophenemalonamic acid disodium salt
NCGC00017046-01
Q27116369
SCHEMBL41223
SCHEMBL41224
SCHEMBL4935403
sodium (2S,5R,6R)-6-((R)-2-carboxylato-2-(thiophen-3-yl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Ticar (TN)
Ticarcillin (disodium)
TICARCILLIN DISODIUM
Ticarcillin disodium (USP)
Ticarcillin disodium [USAN:USP]
Ticarcillin disodium [USAN]
Ticarcillin disodium salt
Ticarcillin Disodium Salt (Contain 10% Methanol)
Ticarcillin disodium salt, >=95%
Ticarcillin disodium salt, 80%
ticarcillin sodium
Ticarcillin sodium (JAN)
Ticarpen
Ticillin
Ticillin disodium
Tox21_110756
UNII-G8TVV6DSYG
VA11873
VA11874
ZX-AFC000251

US Patents and Regulatory Information for TICAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 062690-001 Dec 19, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-005 Apr 4, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TICAR ticarcillin disodium INJECTABLE;INJECTION 050497-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Merck
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.